Bone Solutions

Executive Summary

Bone Solutions is a private orthopedic biologics company based in Colleyville, Texas, focused on developing magnesium-based bone substitute implants. Its flagship product, Mg OSTEOCRETE, is a moldable, injectable, fully resorbable material designed for complex trauma, extremity, revision arthroplasty, sports medicine, and spine surgeries. Founded in 2008, the company aims to improve clinical outcomes by providing a biologically safe alternative to traditional bone grafts. With no disclosed funding rounds or revenue, Bone Solutions appears to be in a pre-revenue or early commercialization stage, likely seeking FDA clearance or CE marking for expanded indications. The magnesium platform offers potential advantages in osteoconductivity and resorption profile, but the company faces competition from established synthetic bone graft players. Conviction is moderate given the lack of public financial data and limited commercial traction.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for Mg OSTEOCRETE in spine fusion65% success
• Q2 2027First-in-human clinical data publication for trauma applications50% success
• Q3 2026Strategic partnership or distribution agreement with a major orthopedic company40% success